Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians-Reference-Cited by-同舟云学术

Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians

Published:2012-12 Issue:12 Volume:22 Page:868-876
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Bertrand Julie,Chou Monidarin,Richardson Danielle M.,Verstuyft Céline,Leger Paul D.,Mentré France,Taburet Anne-Marie,Haas David W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference37 articles.

1. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.;Calmy;AIDS,2006

2. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.;Laurent;Lancet,2004

3. Disposition and biotransformation of the antiretroviral drug nevirapine in humans.;Riska;Drug Metab Dispos,1999

4. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450.;Erickson;Drug Metab Dispos,1999

5. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.;Wen;Drug Metab Dispos,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of albumin and CYP2B6 polymorphisms on exposure of efavirenz: A population pharmacokinetic analysis in Chinese HIV-infected adults;European Journal of Pharmaceutical Sciences;2021-12

2. Could pharmacogenetics aid the prediction of nevirapine pharmacokinetics and allow individualized treatment?;Pharmacogenomics;2021-09

3. Pharmacogenetic predictors of nevirapine pharmacokinetics in Ghanaian children living with HIV with or without TB coinfection;Infection, Genetics and Evolution;2021-08

4. Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana;Pharmacogenomics and Personalized Medicine;2021-03

5. Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine;Pharmacogenetics and Genomics;2020-08-17